232 related articles for article (PubMed ID: 16215677)
1. Inhibition of TRAIL-induced apoptosis by IL-8 is mediated by the p38-MAPK pathway in OVCAR3 cells.
Abdollahi T; Robertson NM; Abdollahi A; Litwack G
Apoptosis; 2005 Dec; 10(6):1383-93. PubMed ID: 16215677
[TBL] [Abstract][Full Text] [Related]
2. Identification of interleukin 8 as an inhibitor of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in the ovarian carcinoma cell line OVCAR3.
Abdollahi T; Robertson NM; Abdollahi A; Litwack G
Cancer Res; 2003 Aug; 63(15):4521-6. PubMed ID: 12907626
[TBL] [Abstract][Full Text] [Related]
3. MAPK p38 and JNK have opposing activities on TRAIL-induced apoptosis activation in NSCLC H460 cells that involves RIP1 and caspase-8 and is mediated by Mcl-1.
Azijli K; Yuvaraj S; van Roosmalen I; Flach K; Giovannetti E; Peters GJ; de Jong S; Kruyt FA
Apoptosis; 2013 Jul; 18(7):851-60. PubMed ID: 23456625
[TBL] [Abstract][Full Text] [Related]
4. Sensitization of apoptotically-resistant breast carcinoma cells to TNF and TRAIL by inhibition of p38 mitogen-activated protein kinase signaling.
Weldon CB; Parker AP; Patten D; Elliott S; Tang Y; Frigo DE; Dugan CM; Coakley EL; Butler NN; Clayton JL; Alam J; Curiel TJ; Beckman BS; Jaffe BM; Burow ME
Int J Oncol; 2004 Jun; 24(6):1473-80. PubMed ID: 15138590
[TBL] [Abstract][Full Text] [Related]
5. p38 MAP kinase pathway and stromelysin regulation in trabecular meshwork cells.
Kelley MJ; Rose A; Song K; Lystrup B; Samples JW; Acott TS
Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):3126-37. PubMed ID: 17591882
[TBL] [Abstract][Full Text] [Related]
6. MKK3/6-p38 MAPK signaling is required for IL-1beta and TNF-alpha-induced RANKL expression in bone marrow stromal cells.
Rossa C; Ehmann K; Liu M; Patil C; Kirkwood KL
J Interferon Cytokine Res; 2006 Oct; 26(10):719-29. PubMed ID: 17032166
[TBL] [Abstract][Full Text] [Related]
7. Diosgenin induces death receptor-5 through activation of p38 pathway and promotes TRAIL-induced apoptosis in colon cancer cells.
Lepage C; Léger DY; Bertrand J; Martin F; Beneytout JL; Liagre B
Cancer Lett; 2011 Feb; 301(2):193-202. PubMed ID: 21195543
[TBL] [Abstract][Full Text] [Related]
8. Peroxiredoxin I contributes to TRAIL resistance through suppression of redox-sensitive caspase activation in human hepatoma cells.
Song IS; Kim SU; Oh NS; Kim J; Yu DY; Huang SM; Kim JM; Lee DS; Kim NS
Carcinogenesis; 2009 Jul; 30(7):1106-14. PubMed ID: 19406930
[TBL] [Abstract][Full Text] [Related]
9. Activation of p38 MAPK by damnacanthal mediates apoptosis in SKHep 1 cells through the DR5/TRAIL and TNFR1/TNF-α and p53 pathways.
Lin FL; Hsu JL; Chou CH; Wu WJ; Chang CI; Liu HJ
Eur J Pharmacol; 2011 Jan; 650(1):120-9. PubMed ID: 20951126
[TBL] [Abstract][Full Text] [Related]
10. Potential for TRAIL as a therapeutic agent in ovarian cancer.
Abdollahi T
Vitam Horm; 2004; 67():347-64. PubMed ID: 15110185
[TBL] [Abstract][Full Text] [Related]
11. Genistein enhances TRAIL-induced apoptosis through inhibition of p38 MAPK signaling in human hepatocellular carcinoma Hep3B cells.
Jin CY; Park C; Kim GY; Lee SJ; Kim WJ; Choi YH
Chem Biol Interact; 2009 Jul; 180(2):143-50. PubMed ID: 19497411
[TBL] [Abstract][Full Text] [Related]
12. Regulation of GDF-8 signaling by the p38 MAPK.
Philip B; Lu Z; Gao Y
Cell Signal; 2005 Mar; 17(3):365-75. PubMed ID: 15567067
[TBL] [Abstract][Full Text] [Related]
13. Pretreatment of docetaxel enhances TRAIL-mediated apoptosis in prostate cancer cells.
Yoo J; Park SS; Lee YJ
J Cell Biochem; 2008 Aug; 104(5):1636-46. PubMed ID: 18404675
[TBL] [Abstract][Full Text] [Related]
14. Lipoxygenase inhibitor MK886 potentiates TRAIL-induced apoptosis through CHOP- and p38 MAPK-mediated up-regulation of death receptor 5 in malignant glioma.
Woo JS; Kim SM; Jeong CH; Ryu CH; Jeun SS
Biochem Biophys Res Commun; 2013 Feb; 431(2):354-9. PubMed ID: 23261452
[TBL] [Abstract][Full Text] [Related]
15. p-Hydroxylcinnamaldehyde from cochinchinamomordica seed reverses resistance to TRAIL in human oesophageal squamous cell carcinoma via the activation of the p38 mitogen-activated protein kinase signalling pathway.
Ma M; Zhang C; Xiang XH; Deng XQ; Dai SL; Wei SS; Zhang XM; Zhao LM; Liu YJ; Shan BE
Biomed Pharmacother; 2020 Jan; 121():109611. PubMed ID: 31731196
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-1 beta induction of neuron apoptosis depends on p38 mitogen-activated protein kinase activity after spinal cord injury.
Wang XJ; Kong KM; Qi WL; Ye WL; Song PS
Acta Pharmacol Sin; 2005 Aug; 26(8):934-42. PubMed ID: 16038625
[TBL] [Abstract][Full Text] [Related]
17. Pomegranate extract inhibits the interleukin-1β-induced activation of MKK-3, p38α-MAPK and transcription factor RUNX-2 in human osteoarthritis chondrocytes.
Rasheed Z; Akhtar N; Haqqi TM
Arthritis Res Ther; 2010; 12(5):R195. PubMed ID: 20955562
[TBL] [Abstract][Full Text] [Related]
18. LY303511 enhances TRAIL sensitivity of SHEP-1 neuroblastoma cells via hydrogen peroxide-mediated mitogen-activated protein kinase activation and up-regulation of death receptors.
Shenoy K; Wu Y; Pervaiz S
Cancer Res; 2009 Mar; 69(5):1941-50. PubMed ID: 19223550
[TBL] [Abstract][Full Text] [Related]
19. Requirement of caspases and p38 MAPK for TRAIL-mediated ICAM-1 expression by human astroglial cells.
Choi K; Song S; Choi C
Immunol Lett; 2008 May; 117(2):168-73. PubMed ID: 18339430
[TBL] [Abstract][Full Text] [Related]
20. TRAIL activates a caspase 9/7-dependent pathway in caspase 8/10-defective SK-N-SH neuroblastoma cells with two functional end points: induction of apoptosis and PGE2 release.
Zauli G; Milani D; Rimondi E; Baldini G; Nicolin V; Grill V; Secchiero P
Neoplasia; 2003; 5(5):457-66. PubMed ID: 14670183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
